Tender conclusion of a non-exclusive discount-5730948

This tender with title Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active substance tranexamic acid (exclusively oral dosage forms), ATC B02AA02 for the period August 1st, 2023 - July 31st, 2025 --

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

has been published on Bidding Source portal dated 26 Jun 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

General Information

Germany

Tender Title :

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active substance tranexamic acid (exclusively oral dosage forms), ATC B02AA02 for the period August 1st, 2023 - July 31st, 2025
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

Tender Type :

Invitation for Bids

Reference No. :

2023/S 117-366509

Country :

Germany

Province/City :

Germany-Hamburg

Publish Date :

26 Jun 2023

Closing Date :

5 Jun 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

425595-Awarded - Germany – Pharmaceutical products – Award of medicinal products as of 01.07.2025 Germany 410786- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 409776- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.08.2025 to 31.07.2027 Germany 404114- Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-09 Germany 405165-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM016 - Arzneimittel - Natriumpräparate Germany 400529- Germany – Pharmaceutical products – Drug discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V within the framework of open-house procedures Germany 398866- Germany – Pharmaceutical products – Pharmaceutical contracts with accession option Germany 400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava Germany 412645-Awarded - Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130c Paragraph 1 SGB V in conjunction with Section 130a Paragraph 8 SGB V for the active ingredient Romosozumab Germany 381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05). Germany

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active substance tranexamic acid (exclusively oral dosage forms), ATC B02AA02 for the period August 1st, 2023 - July 31st, 2025

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

General Information

Germany

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tranexamsäure (ausschließlich orale Darreichungsformen), ATC B02AA02 für die Zeit 01.08.2023 - 31.07.2025

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com